![](/img/cover-not-exists.png)
FDA Approval of Palbociclib in Combination with Fulvestrant for the Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Walker, A. J., Wedam, S., Amiri-Kordestani, L., Bloomquist, E., Tang, S., Sridhara, R., Chen, W., Palmby, T. R., Fourie Zirkelbach, J., Fu, W., Liu, Q., Tilley, A., Kim, G., Kluetz, P. G., McKee, A. ELanguage:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-16-0493
Date:
July, 2016
File:
PDF, 162 KB
english, 2016